SHR-1701 in Combination with BP102 and XELOX As First-Line (1L) Treatment for Patients (pts) with Unresectable Metastatic Colorectal Cancer (mcrc): Data from a Phase II/III Study
ANNALS OF ONCOLOGY(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要